- Home
- VMD vs AQST Comparison
VMD vs AQST Comparison
Compare VMD & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMD
- AQST
- Stock Information
- Founded
- VMD 2006
- AQST 2004
- Country
- VMD United States
- AQST United States
- Employees
- VMD N/A
- AQST N/A
- Industry
- VMD
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- VMD
- AQST Health Care
- Exchange
- VMD Nasdaq
- AQST Nasdaq
- Market Cap
- VMD 279.4M
- AQST 254.1M
- IPO Year
- VMD N/A
- AQST 2018
- Fundamental
- Price
- VMD $6.42
- AQST $2.76
- Analyst Decision
- VMD
- AQST Strong Buy
- Analyst Count
- VMD 0
- AQST 5
- Target Price
- VMD N/A
- AQST $11.40
- AVG Volume (30 Days)
- VMD 154.2K
- AQST 984.2K
- Earning Date
- VMD 05-07-2025
- AQST 05-12-2025
- Dividend Yield
- VMD N/A
- AQST N/A
- EPS Growth
- VMD 19.95
- AQST N/A
- EPS
- VMD 0.30
- AQST N/A
- Revenue
- VMD $232,793,000.00
- AQST $57,561,000.00
- Revenue This Year
- VMD $17.10
- AQST N/A
- Revenue Next Year
- VMD $10.77
- AQST $39.51
- P/E Ratio
- VMD $21.47
- AQST N/A
- Revenue Growth
- VMD 19.97
- AQST 13.79
- 52 Week Low
- VMD $6.21
- AQST $2.20
- 52 Week High
- VMD $9.81
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- VMD 34.08
- AQST 48.51
- Support Level
- VMD $6.80
- AQST $2.65
- Resistance Level
- VMD $7.58
- AQST $3.05
- Average True Range (ATR)
- VMD 0.31
- AQST 0.16
- MACD
- VMD 0.02
- AQST 0.00
- Stochastic Oscillator
- VMD 1.69
- AQST 50.51
About VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.